$135,938 Award for Guillain-Barré Syndrome After Pneumonia Vaccine Injury

A retired man who developed Guillain-Barré Syndrome (GBS) after receiving the Prevnar 13 pneumonia vaccine has received a $135,938 award through the National Vaccine Injury Compensation Program (VICP). Attorneys at mctlaw helped him secure this result without having to go through the stressful experience of a trial.

Before the vaccination, the client was living a full and active life. He enjoyed his retirement and spent quality time with his wife. But everything changed within a few weeks of his pneumonia shot. He began experiencing unusual back pain and numbness, which quickly got worse. He was hospitalized and diagnosed with GBS, a rare but serious neurological disorder linked to certain vaccinations.

He needed intensive medical care and spent time in a rehab center to recover. Even now, he’s still dealing with the lasting effects of GBS. The impact on his health, daily life, and finances has been significant.

After reviewing the evidence, medical records, expert testimony and other legal filings presented by the legal team at mctlaw, the Judge ruled in the client’s favor. This meant the client did not have to endure a long trial to get compensation. 

“The VICP was created to provide fair and fast compensation to people injured by vaccines,” says attorney Anne Toale, a partner at mctlaw. “But in reality, the program is often delayed and difficult to navigate. We are always prepared to fight for our clients and the compensation they deserve.”

The $135,938 settlement covers the client’s past medical expenses and provides compensation for the pain and suffering he experienced because of the vaccine injury.

Guillain-Barre Syndrome vaccine injury claims through the VICP can be complicated and take a long time to work through, which is why having an experienced attorney on your side can make a difference in getting the best outcome.